Zellweger syndrome is a rare disorder that is present at birth (congenital). It is characterized by the reduction or absence of cell structures that rid the body of toxic substances (peroxisomes) in the cells of the liver, kidneys, and brain. Zellweger syndrome is one of a group of genetic disorders called peroxisomal diseases. These affect brain development and the growth of the myelin sheath. That is the fatty covering, which acts as an insulator on nerve fibers in the brain.
The most common features of Zellweger syndrome include:
High levels of iron and copper in the blood.
Some affected infants may show prenatal growth failure. Symptoms at birth may include lack of muscle tone and an inability to move. Other symptoms may include:
Unusual facial characteristics.
Inability to suck and/or swallow.
There is no cure for this syndrome. Nor is there a standard course of treatment. Infections should be guarded against to prevent such complications as pneumonia and respiratory distress. Other treatment is symptomatic and supportive.
The prognosis for patients with this syndrome is poor. Death usually occurs within 6 months after onset. It may be caused by respiratory distress, gastrointestinal bleeding, or liver failure.